Refractory Hypotension in AML: Key Causes and Management

Primary Etiologies to Consider

The American Society of Clinical Oncology recommends that AML patients with severe neutropenia (ANC <1.0 × 10⁹/L) are at extremely high risk for life-threatening infections that can rapidly progress to septic shock 1
Patients with fever and neutropenia constitute a medical emergency requiring immediate blood cultures and broad-spectrum antibiotics before completing any diagnostic workup, as stated by the National Comprehensive Cancer Network 1
The European Society for Medical Oncology notes that the profound immunosuppression from both the disease itself and chemotherapy-induced bone marrow suppression creates vulnerability to overwhelming bacterial, fungal, and opportunistic infections 2, 3
Fungal infections warrant particular attention—thoracic CT and abdominal imaging should be performed to assess for invasive fungal disease affecting liver, spleen, lymph nodes, and kidneys, according to the Infectious Diseases Society of America 2, 4

The American College of Cardiology recommends complete blood count with manual differential to calculate ANC and assess for severity of cytopenias 1
Blood cultures (at least two sets) should be taken before antibiotic administration if fever is present, as advised by the Centers for Disease Control and Prevention 1
A comprehensive coagulation panel including PT, PTT, fibrinogen, and D-dimer should be performed to evaluate for DIC, as recommended by the International Society on Thrombosis and Haemostasis 2, 4

Delaying empiric antibiotics in febrile neutropenia significantly increases mortality—antibiotics must be administered within one hour of presentation, as emphasized by the Surviving Sepsis Campaign 1
The American Society of Clinical Oncology advises against all invasive procedures during severe neutropenia due to infection and bleeding risk 1
If APL is suspected based on clinical presentation (DIC, low WBC with circulating promyelocytes), immediately start ATRA even before cytogenetic confirmation, as recommended by the National Comprehensive Cancer Network 3, 5

Aggressive fluid resuscitation and vasopressor support as needed for hemodynamic stabilization are recommended by the Society of Critical Care Medicine 1
Transfusion support for anemia and thrombocytopenia to maintain adequate oxygen delivery and prevent bleeding is advised by the American Society of Clinical Oncology 3, 5